Unknown NA INTERVENTIONAL 3-arm NCT04295707

Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers (MR1)

Accrued Effect of Orthokeratology for Myopia Control in Children and the Effectiveness of Myopia Control Using an Innovative Orthokeratology Modality. Experiment 1. Effect in Existing Ortho-k Wearers

Sponsor: Menicon Co., Ltd.

Conditions Myopic Progression

Interventions Menicon Progent A+B orthokeratology

Updated 8 times since 2020 Last updated: Jul 18, 2022 Started: Mar 11, 2020 Primary completion: Jun 30, 2023 Completion: Aug 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Myopic Progression, this trial is ongoing. The trial is conducted by Menicon Co., Ltd. and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Active Not Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Mar 2021 — Sep 2022 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — Mar 2021 [monthly]

Recruiting NA
Jun 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2020 — Jun 2020 [monthly]

Not Yet Recruiting NA

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Menicon Co., Ltd.
The Hong Kong Polytechnic University

Data source: The Hong Kong Polytechnic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kowloon, Hong Kong